Miao Xu

Miao Xu

Auto-generated profile, based on publicly available information

Miao Xu

Department of Gastroenterology, The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2023 in Portal Hypertension & Cirrhosis
Verified
Journal Article
Open access
HHHangkai Huang
Hangkai Huang
ZLZhening Liu
Zhening Liu
MXMiao Xu
Miao Xu
YCYishu Chen
Yishu Chen
CXChengfu Xu
Chengfu Xu
Aims: Metabolic dysfunction‐associated fatty liver disease (MAFLD) has become a serious public health challenge and is a cause of liver cancer. Reports on the global epidemiology of MAFLD‐related liver cancer remain limited. This study aimed to estimate the global burden trends of MAFLD‐related liver cancer between 1990 and 2019.Methods: We estimated the numbers of global incident cases, deaths, and disability‐adjusted life years (DALYs) of MAFLD‐related liver cancer by analyzing data from the Global Burden of Disease Study 2019. We also analyzed the trends and regional and national differentials of MAFLD‐related liver cancer. Finally, we investigated the influential factors for the trends in MAFLD‐related liver cancer.Results: Globally, there were 36,340 (95% uncertainty interval [UI]: 29,490–44,860) incident cases, 34,730 (95% UI: 28,390–43,180) deaths, and 795,810 (95% UI: 657,290–975,790) DALYs of MAFLD‐related liver cancer in 2019, representing increases of 205%, 195%, and 166% compared with 1990, respectively. The age‐standardized incidence, mortality, and DALY rates per 100,000 population in 2019 were 0.44, 0.43, and 9.64, respectively. The most pronounced increases in incidence, deaths, and DALYs were consistently observed in countries with a high sociodemographic index. Increasing trends were noted in these three measures since 2005, and the trends were much greater in men than in women.Conclusions: MAFLD‐related liver cancer poses a substantial global burden that continues to grow. Undesirable trends were observed in countries with a high sociodemographic index.

12 April 2023 in Differentiation
Verified
Journal Article
Closed access
WYWenjie Yin
Wenjie Yin
XMXiying Mao
Xiying Mao
MXMiao Xu
Miao Xu
MCMingkang Chen
Mingkang Chen
MXMengting Xue
Mengting Xue
Qinghuai LiuQinghuai Liu
Qinghuai Liu